Noriyuki Sunahara

Title: Noriyuki Sunahara: Innovator in Pharmaceutical Science

Introduction

Noriyuki Sunahara is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceutical science, particularly in the development of methods for determining valproic acid and its derivatives. With a total of 2 patents, his work has implications for immunoassays and antibody production.

Latest Patents

Sunahara's latest patents include a method for the determination of valproic acid and reagents therein. This patent provides .delta.-substituted derivatives of valproic acid for conjugation to antigenic compositions, particularly proteins and enzymes. The antigenic conjugates produced are employed for the production of antibodies, which are particularly useful in immunoassays for the determination of valproate. Additionally, he has developed a kit that contains at least the conjugate and the antibody, along with a determination method for valproate using the kit. Another significant patent involves an insolubilized antibody suitable for enzyme immunoassays or radioimmunoassays. This antibody exhibits characteristic infrared absorptions and is prepared by chemically binding an antibody to cell wall debris of bacteria or yeasts. Furthermore, this patent discloses an enzyme immunoassay or radioimmunoassay using the insolubilized antibody and a kit containing it.

Career Highlights

Sunahara is currently associated with Dainippon Pharmaceutical Company, Limited, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing methods that enhance the accuracy and efficiency of immunoassays.

Collaborations

Throughout his career, Sunahara has collaborated with notable colleagues, including Shigeru Kurooka and Kanae Yokogawa. These collaborations have contributed to the development of his innovative patents and research.

Conclusion

Noriyuki Sunahara's contributions to pharmaceutical science through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to impact the development of immunoassays and antibody production, showcasing the importance of innovation in healthcare.